SciMiner Full MeSH Enrichment

SciMiner Full MeSH Enrichment

Full enrichment MeSH terms (sorted by p-value)

Corpus size :	172	Background :	168	Switch table detail

Rank	MeSH Term	t+	t-	t+ uniq	com mon	b+ uniq	b+	b-	p-value	t-ratio	b-ratio	enrichment folds
1	Reactive Oxygen Species	104	68	103	1	0	1	167	1.63e-39	0.60	0.01	101.6
2	Mitochondria	33	139	33	0	3	3	165	5.80e-08	0.19	0.02	10.7
3	Oxidation-Reduction	27	145	26	1	2	3	165	3.60e-06	0.16	0.02	8.8
4	Oxidative Stress	59	113	56	3	19	22	146	3.99e-06	0.34	0.13	2.6
5	Superoxide Dismutase	69	103	69	0	35	35	133	1.52e-04	0.40	0.21	1.9
6	Microglia	4	168	3	1	21	22	146	1.59e-04	0.02	0.13	0.2
7	Lipid Peroxidation	13	159	0	0	0	0	168	1.95e-04	0.08	0.00	bZero
8	Inflammation Mediators	1	171	0	1	12	13	155	6.97e-04	0.01	0.08	0.1
9	Disease Models, Animal	12	160	11	1	30	31	137	1.74e-03	0.07	0.18	0.4
10	Antioxidants	24	148	23	1	6	7	161	2.16e-03	0.14	0.04	3.3
11	Anti-Inflammatory Agents	1	171	0	1	10	11	157	2.67e-03	0.01	0.07	0.1
12	Free Radicals	18	154	16	2	2	4	164	3.28e-03	0.10	0.02	4.4
13	Free Radical Scavengers	9	163	0	0	0	0	168	3.52e-03	0.05	0.00	bZero
14	Hydrogen Peroxide	9	163	0	0	0	0	168	3.52e-03	0.05	0.00	bZero
15	Tumor Cells, Cultured	9	163	0	0	0	0	168	3.52e-03	0.05	0.00	bZero
16	Cell Line	9	163	0	0	0	0	168	3.52e-03	0.05	0.00	bZero
17	Multiple Sclerosis	1	171	1	0	10	10	158	5.16e-03	0.01	0.06	0.1
18	Calcium	13	159	13	0	2	2	166	6.26e-03	0.08	0.01	6.3
19	DNA, Mitochondrial	8	164	0	0	0	0	168	7.21e-03	0.05	0.00	bZero
20	Aging	18	154	17	1	4	5	163	8.33e-03	0.10	0.03	3.5
21	RNA, Messenger	1	171	1	0	9	9	159	9.88e-03	0.01	0.05	0.1
22	Neuroblastoma	10	162	10	0	1	1	167	1.05e-02	0.06	0.01	9.8
23	Mutation	22	150	22	0	8	8	160	1.20e-02	0.13	0.05	2.7
24	Glutathione Peroxidase	7	165	0	0	0	0	168	1.47e-02	0.04	0.00	bZero
25	DNA Damage	7	165	0	0	0	0	168	1.47e-02	0.04	0.00	bZero
26	Copper	7	165	0	0	0	0	168	1.47e-02	0.04	0.00	bZero
27	Motor Neurons	40	132	39	1	21	22	146	1.70e-02	0.23	0.13	1.8
28	Central Nervous System Diseases	1	171	1	0	8	8	160	1.87e-02	0.01	0.05	0.1
29	Autoimmune Diseases	1	171	1	0	8	8	160	1.87e-02	0.01	0.05	0.1
30	Neurons	30	142	28	2	13	15	153	2.47e-02	0.17	0.09	2.0
31	Adult	8	164	8	0	19	19	149	2.72e-02	0.05	0.11	0.4
32	Neuroglia	3	169	3	0	11	11	157	2.99e-02	0.02	0.07	0.3
33	Prostaglandin-Endoperoxide Synthases	2	170	2	0	9	9	159	3.38e-02	0.01	0.05	0.2
34	Central Nervous System	2	170	2	0	9	9	159	3.38e-02	0.01	0.05	0.2
35	Disease Progression	5	167	5	0	14	14	154	3.42e-02	0.03	0.08	0.3
36	Cells, Cultured	18	154	18	0	7	7	161	3.62e-02	0.10	0.04	2.5
37	Cell Death	19	153	17	2	6	8	160	4.36e-02	0.11	0.05	2.3
38	Middle Aged	15	157	15	0	27	27	141	4.77e-02	0.09	0.16	0.5
39	Apoptosis	25	147	25	0	13	13	155	0.06	0.15	0.08	1.9
40	Cytokines	2	170	2	0	8	8	160	0.06	0.01	0.05	0.2
41	Aldehydes	5	167	0	0	0	0	168	0.06	0.03	0.00	bZero
42	Thiazoles	5	167	0	0	0	0	168	0.06	0.03	0.00	bZero
43	DNA Mutational Analysis	5	167	0	0	0	0	168	0.06	0.03	0.00	bZero
44	Membrane Potentials	5	167	0	0	0	0	168	0.06	0.03	0.00	bZero
45	Glutathione	9	163	8	1	1	2	166	0.06	0.05	0.01	4.4
46	Adolescent	1	171	1	0	6	6	162	0.06	0.01	0.04	0.2
47	Rats	20	152	20	0	10	10	158	0.08	0.12	0.06	2.0
48	Enzyme Inhibitors	10	162	10	0	3	3	165	0.09	0.06	0.02	3.3
49	Cyclooxygenase 2	2	170	2	0	7	7	161	0.10	0.01	0.04	0.3
50	Tumor Necrosis Factor-alpha	2	170	2	0	7	7	161	0.10	0.01	0.04	0.3
51	Gene Expression	2	170	1	1	6	7	161	0.10	0.01	0.04	0.3
52	Immunohistochemistry	6	166	6	0	13	13	155	0.10	0.03	0.08	0.5
53	Nerve Growth Factors	1	171	1	0	5	5	163	0.12	0.01	0.03	0.2
54	Treatment Outcome	1	171	1	0	5	5	163	0.12	0.01	0.03	0.2
55	Macrophages	1	171	1	0	5	5	163	0.12	0.01	0.03	0.2
56	Calcineurin	6	166	6	0	1	1	167	0.12	0.03	0.01	5.9
57	Recombinant Proteins	6	166	6	0	1	1	167	0.12	0.03	0.01	5.9
58	Reactive Nitrogen Species	4	168	0	0	0	0	168	0.12	0.02	0.00	bZero
59	Cyclic N-Oxides	4	168	0	0	0	0	168	0.12	0.02	0.00	bZero
60	Tetrazolium Salts	4	168	0	0	0	0	168	0.12	0.02	0.00	bZero
61	DNA Fragmentation	4	168	0	0	0	0	168	0.12	0.02	0.00	bZero
62	Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization	4	168	0	0	0	0	168	0.12	0.02	0.00	bZero
63	Catalase	4	168	0	0	0	0	168	0.12	0.02	0.00	bZero
64	Metals	4	168	0	0	0	0	168	0.12	0.02	0.00	bZero
65	Aged	14	158	14	0	22	22	146	0.16	0.08	0.13	0.6
66	Transfection	7	165	7	0	2	2	166	0.17	0.04	0.01	3.4
67	Nervous System Diseases	5	167	5	0	10	10	158	0.20	0.03	0.06	0.5
68	Muscular Atrophy	1	171	1	0	4	4	164	0.21	0.01	0.02	0.2
69	Lipopolysaccharides	1	171	1	0	4	4	164	0.21	0.01	0.02	0.2
70	Membrane Glycoproteins	1	171	0	1	3	4	164	0.21	0.01	0.02	0.2
71	Neurotoxins	5	167	5	0	1	1	167	0.21	0.03	0.01	4.9
72	Point Mutation	5	167	5	0	1	1	167	0.21	0.03	0.01	4.9
73	Down-Regulation	5	167	5	0	1	1	167	0.21	0.03	0.01	4.9
74	Cerebral Cortex	5	167	5	0	1	1	167	0.21	0.03	0.01	4.9
75	Brain Diseases	3	169	3	0	7	7	161	0.22	0.02	0.04	0.4
76	Isoenzymes	3	169	3	0	7	7	161	0.22	0.02	0.04	0.4
77	Electron Transport Complex I	3	169	0	0	0	0	168	0.25	0.02	0.00	bZero
78	Friedreich Ataxia	3	169	0	0	0	0	168	0.25	0.02	0.00	bZero
79	Receptors, Kainic Acid	3	169	0	0	0	0	168	0.25	0.02	0.00	bZero
80	Nitric Oxide Synthase Type I	3	169	0	0	0	0	168	0.25	0.02	0.00	bZero
81	Nitroso Compounds	3	169	0	0	0	0	168	0.25	0.02	0.00	bZero
82	Excitatory Amino Acid Agonists	3	169	0	0	0	0	168	0.25	0.02	0.00	bZero
83	Receptors, AMPA	3	169	0	0	0	0	168	0.25	0.02	0.00	bZero
84	Amyloid beta-Protein	3	169	0	0	0	0	168	0.25	0.02	0.00	bZero
85	Cytochrome c Group	3	169	0	0	0	0	168	0.25	0.02	0.00	bZero
86	Melatonin	3	169	0	0	0	0	168	0.25	0.02	0.00	bZero
87	Electron Transport Complex IV	3	169	0	0	0	0	168	0.25	0.02	0.00	bZero
88	Electron Transport	3	169	0	0	0	0	168	0.25	0.02	0.00	bZero
89	Nervous System	3	169	0	0	0	0	168	0.25	0.02	0.00	bZero
90	Ascorbic Acid	3	169	0	0	0	0	168	0.25	0.02	0.00	bZero
91	Homeostasis	3	169	0	0	0	0	168	0.25	0.02	0.00	bZero
92	Fluorescent Dyes	3	169	0	0	0	0	168	0.25	0.02	0.00	bZero
93	Proto-Oncogene Proteins	3	169	0	0	0	0	168	0.25	0.02	0.00	bZero
94	Energy Metabolism	3	169	0	0	0	0	168	0.25	0.02	0.00	bZero
95	Biological Transport	3	169	0	0	0	0	168	0.25	0.02	0.00	bZero
96	Adenosine Triphosphate	3	169	0	0	0	0	168	0.25	0.02	0.00	bZero
97	Survival Rate	4	168	4	0	8	8	160	0.25	0.02	0.05	0.5
98	Mice, Inbred C57BL	4	168	3	1	7	8	160	0.25	0.02	0.05	0.5
99	Parkinson Disease	19	153	18	1	11	12	156	0.26	0.11	0.07	1.5
100	Alzheimer Disease	20	152	18	2	11	13	155	0.27	0.12	0.08	1.5
101	Reverse Transcriptase Polymerase Chain Reaction	2	170	2	0	5	5	163	0.28	0.01	0.03	0.4
102	Motor Neuron Disease	6	166	6	0	10	10	158	0.32	0.03	0.06	0.6
103	Glutamic Acid	11	161	10	1	5	6	162	0.32	0.06	0.04	1.8
104	Motor Activity	3	169	3	0	6	6	162	0.33	0.02	0.04	0.5
105	Aged, 80 and over	3	169	3	0	6	6	162	0.33	0.02	0.04	0.5
106	Nerve Tissue Proteins	12	160	12	0	7	7	161	0.35	0.07	0.04	1.7
107	Cyclooxygenase Inhibitors	1	171	1	0	3	3	165	0.37	0.01	0.02	0.3
108	Drug Delivery Systems	1	171	1	0	3	3	165	0.37	0.01	0.02	0.3
109	Dinoprostone	1	171	1	0	3	3	165	0.37	0.01	0.02	0.3
110	Stroke	1	171	1	0	3	3	165	0.37	0.01	0.02	0.3
111	Brain Neoplasms	1	171	1	0	3	3	165	0.37	0.01	0.02	0.3
112	Polymorphism, Genetic	1	171	1	0	3	3	165	0.37	0.01	0.02	0.3
113	Models, Molecular	1	171	1	0	3	3	165	0.37	0.01	0.02	0.3
114	Mitochondrial Diseases	4	168	4	0	1	1	167	0.37	0.02	0.01	3.9
115	Electrophoresis, Gel, Two-Dimensional	4	168	4	0	1	1	167	0.37	0.02	0.01	3.9
116	Superoxides	4	168	4	0	1	1	167	0.37	0.02	0.01	3.9
117	Proto-Oncogene Proteins c-bcl-2	4	168	4	0	1	1	167	0.37	0.02	0.01	3.9
118	Nitric Oxide Synthase	4	168	4	0	1	1	167	0.37	0.02	0.01	3.9
119	Brain Chemistry	4	168	4	0	1	1	167	0.37	0.02	0.01	3.9
120	Drug Interactions	4	168	4	0	1	1	167	0.37	0.02	0.01	3.9
121	Risk Factors	4	168	4	0	1	1	167	0.37	0.02	0.01	3.9
122	Neuroprotective Agents	15	157	15	0	20	20	148	0.38	0.09	0.12	0.7
123	Blotting, Western	8	164	8	0	4	4	164	0.38	0.05	0.02	2.0
124	Nitric Oxide	9	163	9	0	5	5	163	0.41	0.05	0.03	1.8
125	Riluzole	2	170	2	0	4	4	164	0.44	0.01	0.02	0.5
126	Glial Fibrillary Acidic Protein	2	170	2	0	4	4	164	0.44	0.01	0.02	0.5
127	Oxidants	5	167	5	0	2	2	166	0.45	0.03	0.01	2.4
128	Cell Line, Tumor	5	167	4	1	1	2	166	0.45	0.03	0.01	2.4
129	Enzyme Activation	5	167	5	0	2	2	166	0.45	0.03	0.01	2.4
130	Excitatory Amino Acid Transporter 2	2	170	0	0	0	0	168	0.50	0.01	0.00	bZero
131	Mitochondrial Encephalomyopathies	2	170	0	0	0	0	168	0.50	0.01	0.00	bZero
132	Excitatory Amino Acids	2	170	0	0	0	0	168	0.50	0.01	0.00	bZero
133	Peroxynitrous Acid	2	170	0	0	0	0	168	0.50	0.01	0.00	bZero
134	alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid	2	170	0	0	0	0	168	0.50	0.01	0.00	bZero
135	Ethacrynic Acid	2	170	0	0	0	0	168	0.50	0.01	0.00	bZero
136	Phenylhydrazines	2	170	0	0	0	0	168	0.50	0.01	0.00	bZero
137	Cytochromes c	2	170	0	0	0	0	168	0.50	0.01	0.00	bZero
138	Nitric Oxide Donors	2	170	0	0	0	0	168	0.50	0.01	0.00	bZero
139	Glutathione Reductase	2	170	0	0	0	0	168	0.50	0.01	0.00	bZero
140	Hydroxyl Radical	2	170	0	0	0	0	168	0.50	0.01	0.00	bZero
141	Dizocilpine Maleate	2	170	0	0	0	0	168	0.50	0.01	0.00	bZero
142	Dithiothreitol	2	170	0	0	0	0	168	0.50	0.01	0.00	bZero
143	Kainic Acid	2	170	0	0	0	0	168	0.50	0.01	0.00	bZero
144	Proteome	2	170	0	0	0	0	168	0.50	0.01	0.00	bZero
145	Ketones	2	170	0	0	0	0	168	0.50	0.01	0.00	bZero
146	Aerobiosis	2	170	0	0	0	0	168	0.50	0.01	0.00	bZero
147	Hybrid Cells	2	170	0	0	0	0	168	0.50	0.01	0.00	bZero
148	Aluminum	2	170	0	0	0	0	168	0.50	0.01	0.00	bZero
149	Cell Line, Transformed	2	170	0	0	0	0	168	0.50	0.01	0.00	bZero
150	Genetic Screening	2	170	0	0	0	0	168	0.50	0.01	0.00	bZero
151	Receptors, N-Methyl-D-Aspartate	2	170	0	0	0	0	168	0.50	0.01	0.00	bZero
152	Polymorphism, Single Nucleotide	2	170	0	0	0	0	168	0.50	0.01	0.00	bZero
153	Flavonoids	2	170	0	0	0	0	168	0.50	0.01	0.00	bZero
154	Cataract	2	170	0	0	0	0	168	0.50	0.01	0.00	bZero
155	Protein Processing, Post-Translational	2	170	0	0	0	0	168	0.50	0.01	0.00	bZero
156	Electron Spin Resonance Spectroscopy	2	170	0	0	0	0	168	0.50	0.01	0.00	bZero
157	Phenols	2	170	0	0	0	0	168	0.50	0.01	0.00	bZero
158	Brain Stem	2	170	0	0	0	0	168	0.50	0.01	0.00	bZero
159	Gene Expression Regulation, Enzymologic	2	170	0	0	0	0	168	0.50	0.01	0.00	bZero
160	DNA Repair	2	170	0	0	0	0	168	0.50	0.01	0.00	bZero
161	Linkage (Genetics)	2	170	0	0	0	0	168	0.50	0.01	0.00	bZero
162	L-Lactate Dehydrogenase	2	170	0	0	0	0	168	0.50	0.01	0.00	bZero
163	Embryo, Mammalian	2	170	0	0	0	0	168	0.50	0.01	0.00	bZero
164	Cell Proliferation	2	170	0	0	0	0	168	0.50	0.01	0.00	bZero
165	Models, Chemical	2	170	0	0	0	0	168	0.50	0.01	0.00	bZero
166	Cardiovascular Diseases	2	170	0	0	0	0	168	0.50	0.01	0.00	bZero
167	Saccharomyces cerevisiae	2	170	0	0	0	0	168	0.50	0.01	0.00	bZero
168	Flow Cytometry	2	170	0	0	0	0	168	0.50	0.01	0.00	bZero
169	Oxygen Consumption	2	170	0	0	0	0	168	0.50	0.01	0.00	bZero
170	Risk Assessment	2	170	0	0	0	0	168	0.50	0.01	0.00	bZero
171	Oxygen	2	170	0	0	0	0	168	0.50	0.01	0.00	bZero
172	Erythrocytes	2	170	0	0	0	0	168	0.50	0.01	0.00	bZero
173	Electrophoresis, Polyacrylamide Gel	2	170	0	0	0	0	168	0.50	0.01	0.00	bZero
174	Incidence	2	170	0	0	0	0	168	0.50	0.01	0.00	bZero
175	Kinetics	2	170	0	0	0	0	168	0.50	0.01	0.00	bZero
176	Liver	2	170	0	0	0	0	168	0.50	0.01	0.00	bZero
177	DNA	2	170	0	0	0	0	168	0.50	0.01	0.00	bZero
178	Huntington Disease	6	166	6	0	3	3	165	0.50	0.03	0.02	2.0
179	Animals	104	68	99	5	90	95	73	0.51	0.60	0.57	1.1
180	Mice, Transgenic	20	152	20	0	24	24	144	0.52	0.12	0.14	0.8
181	Spinal Cord	27	145	26	1	30	31	137	0.56	0.16	0.18	0.9
182	Rats, Sprague-Dawley	8	164	8	0	5	5	163	0.57	0.05	0.03	1.6
183	Microdissection	1	171	1	0	2	2	166	0.62	0.01	0.01	0.5
184	Caspase 1	1	171	1	0	2	2	166	0.62	0.01	0.01	0.5
185	Mice, Neurologic Mutants	1	171	1	0	2	2	166	0.62	0.01	0.01	0.5
186	Macrophage Activation	1	171	0	1	1	2	166	0.62	0.01	0.01	0.5
187	Spinal Cord Diseases	1	171	1	0	2	2	166	0.62	0.01	0.01	0.5
188	Caspase 3	1	171	1	0	2	2	166	0.62	0.01	0.01	0.5
189	Drug Design	1	171	1	0	2	2	166	0.62	0.01	0.01	0.5
190	Brain Ischemia	1	171	1	0	2	2	166	0.62	0.01	0.01	0.5
191	Sex Characteristics	1	171	1	0	2	2	166	0.62	0.01	0.01	0.5
192	Enzyme Induction	1	171	1	0	2	2	166	0.62	0.01	0.01	0.5
193	Psychomotor Performance	1	171	1	0	2	2	166	0.62	0.01	0.01	0.5
194	Statistics, Nonparametric	1	171	1	0	2	2	166	0.62	0.01	0.01	0.5
195	Cell Division	1	171	1	0	2	2	166	0.62	0.01	0.01	0.5
196	Drug Therapy, Combination	1	171	1	0	2	2	166	0.62	0.01	0.01	0.5
197	Analysis of Variance	1	171	1	0	2	2	166	0.62	0.01	0.01	0.5
198	Acetylcysteine	3	169	3	0	1	1	167	0.62	0.02	0.01	2.9
199	Proteasome Endopeptidase Complex	3	169	3	0	1	1	167	0.62	0.02	0.01	2.9
200	Cysteine Endopeptidases	3	169	3	0	1	1	167	0.62	0.02	0.01	2.9
201	Multienzyme Complexes	3	169	3	0	1	1	167	0.62	0.02	0.01	2.9
202	Cytosol	3	169	3	0	1	1	167	0.62	0.02	0.01	2.9
203	Binding Sites	3	169	3	0	1	1	167	0.62	0.02	0.01	2.9
204	Amyotrophic Lateral Sclerosis	89	83	88	1	90	91	77	0.67	0.52	0.54	1.0
205	Neurodegenerative Diseases	32	140	28	4	24	28	140	0.67	0.19	0.17	1.1
206	Minocycline	2	170	2	0	3	3	165	0.68	0.01	0.02	0.7
207	Cell Communication	2	170	2	0	3	3	165	0.68	0.01	0.02	0.7
208	Animals, Genetically Modified	4	168	4	0	2	2	166	0.68	0.02	0.01	2.0
209	Humans	132	40	127	5	127	132	36	0.70	0.77	0.79	1.0
210	Excitatory Amino Acid Antagonists	5	167	5	0	3	3	165	0.72	0.03	0.02	1.6
211	Proteins	5	167	5	0	3	3	165	0.72	0.03	0.02	1.6
212	Time Factors	4	168	4	0	5	5	163	0.75	0.02	0.03	0.8
213	Models, Neurological	6	166	6	0	4	4	164	0.75	0.03	0.02	1.5
214	Gene Expression Regulation	6	166	5	1	6	7	161	0.78	0.03	0.04	0.8
215	Dose-Response Relationship, Drug	9	163	9	0	7	7	161	0.80	0.05	0.04	1.3
216	Cell Survival	11	161	11	0	9	9	159	0.82	0.06	0.05	1.2
217	Brain	21	151	20	1	18	19	149	0.87	0.12	0.11	1.1
218	Mice	38	134	37	1	35	36	132	0.90	0.22	0.21	1.0
219	Nerve Degeneration	15	157	15	0	15	15	153	1.00	0.09	0.09	1.0
220	Astrocytes	9	163	9	0	9	9	159	1.00	0.05	0.05	1.0
221	Signal Transduction	10	162	10	0	9	9	159	1.00	0.06	0.05	1.1
222	Coculture Techniques	4	168	4	0	4	4	164	1.00	0.02	0.02	1.0
223	Mice, Knockout	6	166	6	0	5	5	163	1.00	0.03	0.03	1.2
224	Amyloid beta-Protein Precursor	3	169	3	0	2	2	166	1.00	0.02	0.01	1.5
225	Caspases	4	168	4	0	4	4	164	1.00	0.02	0.02	1.0
226	Metallothionein	3	169	3	0	2	2	166	1.00	0.02	0.01	1.5
227	Cell Count	5	167	5	0	5	5	163	1.00	0.03	0.03	1.0
228	Biological Markers	6	166	6	0	5	5	163	1.00	0.03	0.03	1.2
229	Cytoprotection	2	170	2	0	1	1	167	1.00	0.01	0.01	2.0
230	Thioredoxins	2	170	1	1	0	1	167	1.00	0.01	0.01	2.0
231	Cycas	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
232	DNA Breaks, Single-Stranded	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
233	NADPH Oxidase	2	170	1	1	1	2	166	1.00	0.01	0.01	1.0
234	Capillary Electrochromatography	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
235	Gerstmann-Straussler-Scheinker Disease	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
236	Erucic Acids	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
237	Tyrosine	3	169	3	0	2	2	166	1.00	0.02	0.01	1.5
238	Longevity	2	170	1	1	1	2	166	1.00	0.01	0.01	1.0
239	Immunophilins	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
240	Apoptosis Inducing Factor	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
241	Deoxyribonuclease IV (Phage T4-Induced)	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
242	Apoptotic Protease-Activating Factor 1	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
243	Intercellular Signaling Peptides and Proteins	2	170	1	1	0	1	167	1.00	0.01	0.01	2.0
244	Cyclic ADP-Ribose	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
245	Bystander Effect	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
246	Spin Trapping	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
247	Heterocyclic Compounds, 3-Ring	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
248	Phagocyte Bactericidal Dysfunction	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
249	Silver Compounds	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
250	Reducing Agents	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
251	NF-E2-Related Factor 2	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
252	Bulbar Palsy, Progressive	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
253	S-Nitrosoglutathione	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
254	Reperfusion Injury	2	170	2	0	1	1	167	1.00	0.01	0.01	2.0
255	Amino Acids, Diamino	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
256	Clioquinol	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
257	Sodium Cyanide	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
258	X-Linked Inhibitor of Apoptosis Protein	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
259	Sirtuins	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
260	Disease	2	170	2	0	1	1	167	1.00	0.01	0.01	2.0
261	Enzyme Activators	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
262	Aconitate Hydratase	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
263	Dibucaine	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
264	Benzoic Acids	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
265	Peroxiredoxins	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
266	Lewy Bodies	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
267	DNA-(Apurinic or Apyrimidinic Site) Lyase	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
268	Zinc Sulfate	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
269	Iron, Dietary	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
270	Lewy Body Disease	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
271	Mitochondrial Myopathies	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
272	Adrenoleukodystrophy	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
273	Ubiquitin Thiolesterase	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
274	2,4-Dinitrophenol	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
275	Oncogene Protein p21(ras)	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
276	Amino Acid Transport System X-AG	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
277	Radioactive Pollutants	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
278	Xanthine	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
279	Vascular Endothelial Growth Factor A	2	170	2	0	2	2	166	1.00	0.01	0.01	1.0
280	Nitrates	2	170	2	0	1	1	167	1.00	0.01	0.01	2.0
281	Receptor, Nerve Growth Factor	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
282	Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
283	Trigeminal Nuclei	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
284	Triolein	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
285	Potassium Cyanide	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
286	rac1 GTP-Binding Protein	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
287	Membrane Proteins	4	168	4	0	4	4	164	1.00	0.02	0.02	1.0
288	Ditiocarb	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
289	Cell Respiration	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
290	Lipofuscin	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
291	Trans-Activation (Genetics)	2	170	2	0	1	1	167	1.00	0.01	0.01	2.0
292	Electron Transport Complex III	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
293	Dermis	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
294	Ruthenium Red	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
295	Muscular Atrophy, Spinal	1	171	1	0	1	1	167	1.00	0.01	0.01	1.0
296	Succinic Acid	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
297	Molsidomine	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
298	Oligodeoxyribonucleotides, Antisense	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
299	Sphingomyelin Phosphodiesterase	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
300	Buthionine Sulfoximine	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
301	Glutamates	2	170	2	0	1	1	167	1.00	0.01	0.01	2.0
302	Head Injuries, Closed	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
303	Phenanthridines	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
304	Benzothiazoles	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
305	Thioctic Acid	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
306	Calcium-Calmodulin-Dependent Protein Kinase Type 2	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
307	Metalloporphyrins	1	171	1	0	1	1	167	1.00	0.01	0.01	1.0
308	6-Cyano-7-nitroquinoxaline-2,3-dione	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
309	NF-kappa B	2	170	2	0	2	2	166	1.00	0.01	0.01	1.0
310	Granulomatous Disease, Chronic	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
311	Soccer	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
312	Mitochondrial Swelling	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
313	Lithium Carbonate	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
314	Feedback, Biochemical	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
315	Rotenone	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
316	Acetophenones	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
317	Pargyline	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
318	Ryanodine	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
319	Prion Diseases	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
320	Biotinylation	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
321	Citrulline	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
322	Torpedo	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
323	Carboxyhemoglobin	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
324	AIDS Dementia Complex	1	171	1	0	1	1	167	1.00	0.01	0.01	1.0
325	Indans	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
326	Calcium Radioisotopes	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
327	Adenosine Diphosphate Ribose	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
328	Muscle, Skeletal	3	169	3	0	2	2	166	1.00	0.02	0.01	1.5
329	Glycosylation End Products, Advanced	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
330	Plant Poisoning	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
331	Cardiolipins	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
332	Uncoupling Agents	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
333	Hyperkinesis	1	171	1	0	1	1	167	1.00	0.01	0.01	1.0
334	Drug Administration Routes	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
335	Naphthoquinones	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
336	Heme Oxygenase (Decyclizing)	1	171	0	1	0	1	167	1.00	0.01	0.01	1.0
337	Heterozygote	2	170	2	0	1	1	167	1.00	0.01	0.01	2.0
338	Ryanodine Receptor Calcium Release Channel	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
339	Paraquat	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
340	I-kappa B Proteins	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
341	Cell Extracts	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
342	Nerve Growth Factor	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
343	Malonates	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
344	Nitrogen Oxides	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
345	Propylamines	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
346	Deoxyguanosine	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
347	Catechin	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
348	Iron Chelating Agents	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
349	Neurofilament Proteins	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
350	Fura-2	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
351	Models, Biological	5	167	5	0	4	4	164	1.00	0.03	0.02	1.2
352	Molecular Mimicry	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
353	Stilbenes	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
354	Muscle Denervation	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
355	Molecular Structure	3	169	3	0	3	3	165	1.00	0.02	0.02	1.0
356	Pyruvic Acid	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
357	Rhodamines	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
358	Tea	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
359	Spinal Nerves	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
360	Cerebellar Cortex	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
361	Hemostatics	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
362	Rats, Inbred BN	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
363	Spermine	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
364	Metalloproteins	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
365	Electrophoretic Mobility Shift Assay	1	171	1	0	1	1	167	1.00	0.01	0.01	1.0
366	Cyclooxygenase 2 Inhibitors	1	171	1	0	1	1	167	1.00	0.01	0.01	1.0
367	Staurosporine	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
368	Baculoviridae	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
369	Cardiovascular Agents	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
370	Muscle Spasticity	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
371	Thiobarbituric Acid Reactive Substances	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
372	Databases, Protein	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
373	Lyases	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
374	Receptors, Glutamate	1	171	1	0	1	1	167	1.00	0.01	0.01	1.0
375	Spodoptera	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
376	Cysteine Proteinase Inhibitors	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
377	Ubiquitin-Protein Ligases	1	171	0	1	0	1	167	1.00	0.01	0.01	1.0
378	Rats, Wistar	4	168	4	0	3	3	165	1.00	0.02	0.02	1.3
379	Xanthine Oxidase	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
380	Prosencephalon	1	171	1	0	1	1	167	1.00	0.01	0.01	1.0
381	Mitochondrial Proteins	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
382	Quinoxalines	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
383	Enzyme-Linked Immunosorbent Assay	3	169	3	0	2	2	166	1.00	0.02	0.01	1.5
384	Xanthines	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
385	Spin Labels	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
386	Immunologic Factors	1	171	0	1	0	1	167	1.00	0.01	0.01	1.0
387	Dopamine Agonists	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
388	Oxygenases	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
389	Forelimb	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
390	Protein Synthesis Inhibitors	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
391	Interleukins	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
392	Atherosclerosis	1	171	1	0	1	1	167	1.00	0.01	0.01	1.0
393	Choline O-Acetyltransferase	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
394	Organ Transplantation	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
395	Vitamin K	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
396	Creatine	1	171	1	0	1	1	167	1.00	0.01	0.01	1.0
397	Spinal Injuries	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
398	Necrosis	2	170	2	0	1	1	167	1.00	0.01	0.01	2.0
399	Genetic Predisposition to Disease	2	170	2	0	2	2	166	1.00	0.01	0.01	1.0
400	Metabolic Diseases	1	171	1	0	1	1	167	1.00	0.01	0.01	1.0
401	Therapeutics	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
402	Mutagenesis, Site-Directed	2	170	2	0	1	1	167	1.00	0.01	0.01	2.0
403	Facial Nerve	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
404	NADH, NADPH Oxidoreductases	1	171	1	0	1	1	167	1.00	0.01	0.01	1.0
405	Thiamine	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
406	Schistosoma mansoni	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
407	Diterpenes	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
408	Cell Fusion	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
409	Microdialysis	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
410	Vascular Endothelial Growth Factors	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
411	Hydrazines	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
412	N-Methylaspartate	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
413	Endothelial Growth Factors	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
414	Genetic Vectors	2	170	2	0	1	1	167	1.00	0.01	0.01	2.0
415	Mitochondria, Muscle	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
416	HSP70 Heat-Shock Proteins	1	171	1	0	1	1	167	1.00	0.01	0.01	1.0
417	PC12 Cells	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
418	Gerbillinae	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
419	Culture Media, Conditioned	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
420	Monoamine Oxidase Inhibitors	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
421	Mass Spectrometry	2	170	2	0	1	1	167	1.00	0.01	0.01	2.0
422	Italy	2	170	2	0	1	1	167	1.00	0.01	0.01	2.0
423	Metabolism, Inborn Errors	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
424	Monoamine Oxidase	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
425	Lipid Peroxides	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
426	Mitochondria, Heart	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
427	MAP Kinase Signaling System	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
428	Vacuoles	1	171	1	0	1	1	167	1.00	0.01	0.01	1.0
429	Antigens, CD95	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
430	Dinoprost	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
431	Phosphodiesterase Inhibitors	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
432	Phosphoprotein Phosphatases	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
433	NG-Nitroarginine Methyl Ester	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
434	Transgenes	1	171	0	1	0	1	167	1.00	0.01	0.01	1.0
435	Proto-Oncogene Proteins c-akt	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
436	Glioblastoma	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
437	Pesticides	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
438	Calcium Signaling	1	171	1	0	1	1	167	1.00	0.01	0.01	1.0
439	Proteomics	1	171	1	0	1	1	167	1.00	0.01	0.01	1.0
440	Acetylation	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
441	Synaptosomes	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
442	Malondialdehyde	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
443	Molecular Sequence Data	1	171	1	0	1	1	167	1.00	0.01	0.01	1.0
444	Alcohol Oxidoreductases	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
445	Microscopy, Immunoelectron	1	171	1	0	1	1	167	1.00	0.01	0.01	1.0
446	Succinate Dehydrogenase	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
447	Calcium-Calmodulin-Dependent Protein Kinases	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
448	Pyrazoles	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
449	Electrons	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
450	Glucosephosphate Dehydrogenase	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
451	Motor Cortex	1	171	1	0	1	1	167	1.00	0.01	0.01	1.0
452	Fluoresceins	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
453	Disulfides	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
454	Glutamine	1	171	0	1	0	1	167	1.00	0.01	0.01	1.0
455	Purines	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
456	Quinolines	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
457	Hippocampus	2	170	2	0	1	1	167	1.00	0.01	0.01	2.0
458	Alternative Splicing	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
459	Choline	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
460	Osteosarcoma	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
461	1-Phosphatidylinositol 3-Kinase	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
462	Peroxidases	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
463	Membrane Lipids	1	171	1	0	1	1	167	1.00	0.01	0.01	1.0
464	Sciatic Nerve	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
465	Family Health	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
466	Cardiovascular System	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
467	Ischemic Attack, Transient	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
468	Cytoskeletal Proteins	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
469	Nerve Regeneration	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
470	Blood-Brain Barrier	1	171	1	0	1	1	167	1.00	0.01	0.01	1.0
471	Granulocytes	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
472	Arachidonic Acid	1	171	1	0	1	1	167	1.00	0.01	0.01	1.0
473	Fruit	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
474	Neuronal Plasticity	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
475	Uric Acid	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
476	Intracellular Signaling Peptides and Proteins	1	171	1	0	1	1	167	1.00	0.01	0.01	1.0
477	Caffeine	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
478	Genes, Dominant	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
479	Endothelium	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
480	Lymphokines	1	171	1	0	1	1	167	1.00	0.01	0.01	1.0
481	Buffers	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
482	Cadmium	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
483	Down Syndrome	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
484	NADP	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
485	Heat-Shock Proteins	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
486	Aspartic Acid	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
487	Lens, Crystalline	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
488	Seeds	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
489	Cycloheximide	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
490	Glycosylation	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
491	Organ Culture Techniques	1	171	1	0	1	1	167	1.00	0.01	0.01	1.0
492	Neck	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
493	Histocompatibility Antigens Class II	1	171	1	0	1	1	167	1.00	0.01	0.01	1.0
494	Acetates	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
495	Adenoviridae	1	171	1	0	1	1	167	1.00	0.01	0.01	1.0
496	Permeability	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
497	Neurologic Examination	1	171	1	0	1	1	167	1.00	0.01	0.01	1.0
498	Mitogen-Activated Protein Kinases	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
499	Vitamin E	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
500	Amino Acid Substitution	1	171	1	0	1	1	167	1.00	0.01	0.01	1.0
501	Pyrimidines	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
502	Hypothyroidism	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
503	Animals, Newborn	2	170	2	0	2	2	166	1.00	0.01	0.01	1.0
504	Cyclosporine	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
505	Glioma	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
506	Lactic Acid	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
507	Endopeptidases	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
508	Lasers	1	171	1	0	1	1	167	1.00	0.01	0.01	1.0
509	GTP-Binding Proteins	1	171	1	0	1	1	167	1.00	0.01	0.01	1.0
510	Tomography, Emission-Computed	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
511	Steroids	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
512	Drosophila	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
513	Protein Folding	1	171	0	1	0	1	167	1.00	0.01	0.01	1.0
514	Gene Deletion	1	171	1	0	1	1	167	1.00	0.01	0.01	1.0
515	Sulfonamides	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
516	Capillaries	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
517	Tumor Suppressor Protein p53	1	171	1	0	1	1	167	1.00	0.01	0.01	1.0
518	Piperazines	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
519	Fertility	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
520	Enzymes	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
521	Cell Membrane Permeability	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
522	gamma-Aminobutyric Acid	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
523	Carbon Radioisotopes	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
524	Neural Pathways	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
525	Mortality	1	171	1	0	1	1	167	1.00	0.01	0.01	1.0
526	Pyridines	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
527	Clone Cells	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
528	Oligopeptides	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
529	Imidazoles	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
530	Thymidine	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
531	Cerebellum	1	171	1	0	1	1	167	1.00	0.01	0.01	1.0
532	Protein-Serine-Threonine Kinases	1	171	1	0	1	1	167	1.00	0.01	0.01	1.0
533	Amino Acid Sequence	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
534	Immunoblotting	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
535	Seizures	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
536	Follow-Up Studies	1	171	1	0	1	1	167	1.00	0.01	0.01	1.0
537	Serum Albumin	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
538	Oxidoreductases	1	171	1	0	1	1	167	1.00	0.01	0.01	1.0
539	Ischemia	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
540	Protein Conformation	2	170	2	0	2	2	166	1.00	0.01	0.01	1.0
541	Monitoring, Physiologic	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
542	Antibody Specificity	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
543	Lipid Metabolism	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
544	Interferon Type II	1	171	1	0	1	1	167	1.00	0.01	0.01	1.0
545	Exercise Test	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
546	Zinc	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
547	Crystallography, X-Ray	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
548	Plant Extracts	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
549	Cerebrovascular Disorders	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
550	Arteries	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
551	Acetylcholine	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
552	Brain Mapping	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
553	Anoxia	1	171	1	0	1	1	167	1.00	0.01	0.01	1.0
554	Exercise	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
555	Catalysis	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
556	Cell Cycle	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
557	Contrast Media	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
558	Drug Combinations	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
559	Stereoisomerism	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
560	Tumor Markers, Biological	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
561	Epilepsy	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
562	Phospholipids	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
563	Diagnosis, Differential	1	171	1	0	1	1	167	1.00	0.01	0.01	1.0
564	Nuclear Proteins	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
565	Macromolecular Substances	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
566	Pilot Projects	1	171	1	0	1	1	167	1.00	0.01	0.01	1.0
567	Ligands	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
568	Dopamine	1	171	1	0	1	1	167	1.00	0.01	0.01	1.0
569	Electromyography	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
570	Glycoproteins	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
571	Spectrophotometry	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
572	Blood Platelets	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
573	Ethanol	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
574	Pedigree	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
575	Blood Proteins	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
576	Iron	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
577	Action Potentials	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
578	Organ Size	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
579	Neoplasms	3	169	3	0	3	3	165	1.00	0.02	0.02	1.0
580	Recombinant Fusion Proteins	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
581	Respiration	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
582	Histocytochemistry	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
583	Statistics as Topic	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
584	Chromosome Mapping	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
585	Japan	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
586	Antibodies	1	171	1	0	1	1	167	1.00	0.01	0.01	1.0
587	Peptide Fragments	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
588	Fibroblasts	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
589	Fluorescent Antibody Technique	1	171	1	0	1	1	167	1.00	0.01	0.01	1.0
590	Diet	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
591	Plasmids	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
592	Genotype	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
593	Cross-Sectional Studies	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
594	Culture Media	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
595	Cell Nucleus	1	171	1	0	1	1	167	1.00	0.01	0.01	1.0
596	Phosphorylation	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
597	Mental Disorders	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
598	Transcription Factors	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
599	Mice, Inbred BALB C	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
600	Peptides	1	171	1	0	1	1	167	1.00	0.01	0.01	1.0
601	Reproducibility of Results	2	170	2	0	1	1	167	1.00	0.01	0.01	2.0
602	Magnetic Resonance Imaging	2	170	2	0	1	1	167	1.00	0.01	0.01	2.0
603	Cattle	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
604	Body Weight	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
605	Age Factors	2	170	2	0	2	2	166	1.00	0.01	0.01	1.0
606	Hypertension	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
607	Sensitivity and Specificity	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
608	Heart	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
609	Chronic Disease	1	171	1	0	1	1	167	1.00	0.01	0.01	1.0
610	Amino Acids	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
611	Polymerase Chain Reaction	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
612	Biopsy	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
613	Escherichia coli	1	171	0	0	0	0	168	1.00	0.01	0.00	bZero
614	Glucose	1	171	1	0	1	1	167	1.00	0.01	0.01	1.0

Full result (HTML, TXT, EXCEL)